A Clinical Investigation on Early Visible Effects of Application of K101 During 8 Weeks on Discoloured and Deformed Nails Resulting From Onychomycosis

NCT01180491 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2013-06-26

No results posted yet for this study

Summary

The purpose of this study is to further evaluate and document early visible effects on nail appearance of topical K101.

Conditions

  • Onychomycosis

Interventions

DEVICE

K101 nail solution

Sponsors & Collaborators

  • Moberg Pharma AB

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2010-11-30
Completion
2010-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01180491 on ClinicalTrials.gov